How to Get iLink® Corneal Cross-Linking Covered by Aetna in California: Complete Prior Authorization Guide

Answer Box: Getting iLink® Covered by Aetna in California

Aetna requires prior authorization for iLink® corneal cross-linking (CPT 0402T) for keratoconus in California. Submit your request through AetnaElectronicPrecert.com with documented corneal progression, failed conservative treatments, and corneal thickness ≥400μm. If denied, file an internal appeal within 180 days, then request an Independent Medical Review (IMR) through California's DMHC. Success rates for specialty treatment appeals are favorable in California's consumer-friendly system.

First step today: Contact your eye doctor to document keratoconus progression and initiate the prior authorization process well before your planned procedure date.

Table of Contents

  1. Coverage Requirements at a Glance
  2. Step-by-Step: Fastest Path to Approval
  3. Medical Necessity Documentation
  4. Common Denial Reasons & Solutions
  5. Appeals Process in California
  6. Finding In-Network Providers
  7. Cost and Financial Assistance
  8. FAQ

Coverage Requirements at a Glance

Requirement Details Source
Prior Authorization Required for CPT 0402T (keratoconus H18.6) Aetna Precertification List
Diagnosis Progressive keratoconus with documented progression Clinical policy
Corneal Thickness Minimum 400μm at thinnest point FDA safety requirement
Prior Treatments Failed glasses/contact lenses documented Medical necessity criteria
Submission Method Electronic portal or phone authorization Aetna Precertification
Appeal Deadline 180 days from denial notice Aetna California Appeals

Step-by-Step: Fastest Path to Approval

1. Document Disease Progression

Who: Your ophthalmologist
Timeline: Ongoing monitoring (every 3-6 months recommended)
Required: Serial corneal topography showing steepening >1D in maximum keratometry or increasing astigmatism/myopia over 12 months

2. Confirm Eligibility Criteria

Who: Clinical team
Documents needed:

  • Corneal pachymetry showing ≥400μm thickness
  • No history of herpes simplex keratitis
  • Failed conservative management (glasses, contact lenses)
  • Progressive keratoconus diagnosis (ICD-10: H18.6)

3. Submit Prior Authorization

Who: Provider's office
Method: AetnaElectronicPrecert.com or phone
Timeline: Submit 2-3 weeks before planned procedure
Required information:

  • Member ID and demographics
  • Provider NPI
  • CPT code 0402T
  • ICD-10 code H18.6
  • Clinical documentation package

4. Prepare Supporting Documentation

Clinical notes must include:

  • Documented progression evidence
  • Prior treatment failures
  • Contraindication screening results
  • Treatment goals and expected outcomes

5. Track Decision Timeline

Standard review: No published timeframe from Aetna
Expedited review: Available for urgent cases (72 hours in California)
Follow up: Contact Aetna if no response within 2 weeks

Medical Necessity Documentation

Clinician Corner: Your medical necessity letter should clearly establish progressive keratoconus with objective evidence and failed conservative management.

Essential components for approval:

Disease Progression Evidence:

  • Serial topography showing corneal steepening
  • Increasing astigmatism or myopia measurements
  • Declining visual acuity despite correction
  • Timeline demonstrating progression over 6-12 months

Treatment History:

  • Spectacle correction attempts and limitations
  • Contact lens trials (rigid gas permeable preferred)
  • Reasons for treatment failures or intolerance

Safety Criteria:

  • Corneal pachymetry measurements ≥400μm
  • Absence of corneal scarring or active infection
  • No history of herpes simplex keratitis

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by identifying the specific denial basis and drafting point-by-point rebuttals aligned to each plan's requirements. Their platform helps clinicians prepare stronger initial submissions and appeals for specialty treatments like corneal cross-linking.

Common Denial Reasons & Solutions

Denial Reason Solution Strategy
"Not medically necessary" Submit additional progression documentation, peer-reviewed studies showing CXL effectiveness (>93% stabilization rate)
"Experimental/investigational" Emphasize FDA approval since 2016; cite that iLink® is covered by 95% of commercial plans
"Non-participating provider" Request single-case agreement or find in-network specialist
"Insufficient documentation" Provide comprehensive packet with serial imaging, visual acuity records, contact lens fitting notes
"Alternative treatments available" Document failures/contraindications to scleral lenses, explain CXL is only disease-modifying treatment

Appeals Process in California

Internal Appeal (Level 1)

Timeline: File within 180 days of denial
Method: Written or phone appeal to Aetna
Decision time: Generally 30 days (expedited available)
Required: Denial letter, additional clinical evidence, provider statement

Independent Medical Review (IMR)

When: After internal appeal denial or 30-day non-response
Regulator: California Department of Managed Health Care (DMHC)
Timeline: 45 days for standard, 7 days for expedited
Success rate: High for medically justified specialty treatments
Cost: No fee to patient

To request IMR:

  1. Contact DMHC Help Center at 888-466-2219
  2. Submit written request with supporting documentation
  3. Include Aetna's final determination letter
  4. Provide all relevant medical records
Note: California's IMR process is binding on insurers and has favorable outcomes for patients with well-documented medical necessity.

Finding In-Network Providers

Northern California:

  • San Francisco Eye Institute (Bay Area)
  • Spectrum Eye Physicians (San Jose, Cupertino, Los Gatos)
  • Optima Eye (Bay Area)

Southern California:

  • UCLA Stein Eye Institute (Los Angeles)
  • Coastal Vision Medical Group (Orange County)
  • 90210 Eyes (Beverly Hills)
  • Fuerst Eye Center (Glendale)

Central California:

  • Santa Barbara Eyecare
Tip: Contact providers directly to verify current Aetna network participation, as this can vary by specific plan type.

Cost and Financial Assistance

Typical procedure costs: $2,500-$4,000 per eye
Insurance coverage: Over 95% of commercial plans cover FDA-approved CXL

Financial assistance options:

Frequently Asked Questions

How long does Aetna prior authorization take in California?
Aetna doesn't publish standard timeframes, but most decisions come within 2-3 weeks. Expedited review is available for urgent cases with 72-hour decisions required by California law.

What if iLink® is considered non-formulary?
Since iLink® is a medical device/procedure rather than a pharmacy benefit, formulary status typically doesn't apply. Coverage is based on medical necessity and prior authorization approval.

Can I request an expedited appeal if my keratoconus is rapidly progressing?
Yes, California law requires expedited appeals for urgent medical situations. Document rapid progression and request expedited review at both internal appeal and IMR levels.

What happens if Aetna approves but limits the number of treatments?
Most approvals cover bilateral treatment (both eyes) when medically necessary. If limited to one eye, appeal with documentation of bilateral disease progression.

Do I need a referral from my primary care doctor?
This depends on your specific Aetna plan type. HMO plans typically require referrals, while PPO plans may allow direct specialist access. Check your member handbook or call member services.

What if I've already had the procedure and need to appeal a claim denial?
File a claim appeal with the same documentation requirements. California allows post-service appeals with similar timelines and IMR rights.

When to Escalate

Contact California regulators if:

  • Aetna doesn't respond within required timeframes
  • Appeal process isn't followed properly
  • You need assistance navigating the system

California Department of Managed Health Care (DMHC):
Phone: 888-466-2219
Website: healthhelp.ca.gov

For additional support: Counterforce Health helps patients and providers navigate complex prior authorization and appeals processes, turning denials into successful approvals through evidence-based advocacy.


Disclaimer: This information is for educational purposes only and is not medical advice. Coverage policies and requirements may change. Always verify current information with Aetna and consult your healthcare provider for medical decisions. For official appeals assistance in California, contact the DMHC Help Center at 888-466-2219.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.